Mortalin was shown to inhibit tumor suppressor p53 function by interacting with it in the cytoplasm [8] as well as in nucleus [2, 9], where it controls centrosome duplication, activates telomerase and hnRNPK yielding malignant properties of cancer cells [2]. This evidence concerns the gene HNRNPK and cancer.